4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-004579
Options or other derivatives
- Chief Executive Officer acquired 565,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-01-18 | Grant or award : show line 1 in the form Stock Option(right to buy) | +565,000 | $7.53 | 2029-01-18 | 565,000 | 565,000 | D |
Loading xslF345X03/doc4.xml…